The latest financial statement is for the quarter ending 2025-12-27.
| Cash Flow | 2025-12-27 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|
| Net loss | -14,800 | -20,600 | -47,800 |
| Intangible asset impairment charge | - | - | 13,800 |
| Share-based compensation | 38,700 | 36,700 | 112,800 |
| Depreciation | 7,600 | 7,500 | 28,900 |
| Acquired intangible assets amortization | 34,000 | 35,200 | 114,200 |
| Deferred taxes | 5,300 | 4,200 | 75,400 |
| Income taxes payable | - | - | -43,300 |
| Other | -3,100 | -2,400 | -24,700 |
| Other accrued liabilities | - | - | 4,100 |
| Accounts receivable, net | 13,200 | -10,800 | -12,300 |
| Inventories, net | 15,500 | 2,900 | 25,100 |
| Prepaid expenses and other current and non-current assets | 2,500 | -3,900 | -12,000 |
| Accounts payable | 1,800 | -7,000 | 10,800 |
| Advance payment on intangible assets | - | - | 0 |
| Accrued liabilities | -4,100 | -31,600 | - |
| Purchase of intangible assets | - | - | 10,000 |
| Net cash provided by operating activities | 29,800 | 30,200 | 142,000 |
| Acquisition of business, net of cash and cash equivalents acquired | 0 | - | 201,100 |
| Other | - | - | 0 |
| Proceeds from sale of investments | - | - | 0 |
| Purchases of short-term investments | - | - | 61,000 |
| Proceeds from maturity of investments | 0 | 61,000 | 0 |
| Purchases of property and equipment | 11,600 | 12,200 | 25,800 |
| Net cash provided by (used in) investing activities | -11,600 | 48,800 | -297,900 |
| Proceeds from issuance of convertible senior notes, net of issuance costs | 0 | - | 439,500 |
| Payment of debt issuance costs on convertible senior notes and revolving credit facility | 0 | - | 4,400 |
| Payments for capped call transactions related to the convertible senior notes | 0 | - | 49,900 |
| Repurchases of common stock, excluding excise taxes | 36,400 | 7,200 | 128,300 |
| Proceeds from issuance of shares | 0 | 7,400 | 13,900 |
| Payroll taxes related to net share settlement of share-based awards | 4,300 | 10,600 | 19,600 |
| Repayment of debt | 0 | 0 | -583,500 |
| Other | 0 | 0 | 900 |
| Net cash used in financing activities | -40,700 | -10,400 | -331,400 |
| Effect of exchange rate changes on cash and cash equivalents | 0 | -200 | - |
| Net increase (decrease) in cash and cash equivalents | -22,500 | 68,400 | - |
| Effect of exchange rate changes on cash and cash equivalents | - | - | 1,900 |
| Cash and cash equivalents at beginning of period | 459,900 | 391,500 | - |
| Net (decrease)/increase in cash and cash equivalents | - | - | -485,400 |
| Cash and cash equivalents at end of period | 437,400 | 459,900 | - |
SYNAPTICS Inc (SYNA)
SYNAPTICS Inc (SYNA)